Hook & thesis
CoreWeave is no longer just a revenue growth story — the unit economics are beginning to show through. The company reported Q2 sales of $2.6 billion (up 112% year-over-year) and posted adjusted EBITDA of $1.5 billion, a sign that operating leverage is taking hold as AI infrastructure demand surges. At the same time, the business is hitting its accelerators: a record $104.2 billion backlog and raised 2026 revenue guidance of $12.4-$13.2 billion suggest demand will continue to drive scale.
That bullish setup collides with a stressed balance sheet. Quarterly capex near $9.4 billion, $43.5 billion in long-term debt (per recent reporting), and a cash burn reflected in negative free cash flow of roughly $13.7 billion are real constraints. The company's recent capital raises - a 35 million share ATM program and a $3 billion convertible notes offering announced 09/17/2026 - weigh on near-term shareholder returns.
My view: the economics are starting to change in CoreWeave's favor, but investors must respect the financing risk. This is a structured long: take a core stake while tightly limiting downside with a stop-loss and using a 180-trading-day time horizon for the thesis to play out.
What CoreWeave does and why the market should care
CoreWeave provides high-performance cloud compute tailored to AI, ML, visual effects and large-scale batch processing workloads. Unlike generic public cloud, CoreWeave optimizes for GPU-intensive workloads and offers specialized clusters (recently multi-rack NVIDIA Vera Rubin NVL72 deployments) and storage features crafted for agentic AI and large model training.
Why it matters: hyperscaler and enterprise AI demand is creating a structural wave for specialized GPU infrastructure. Jensen Huang's $3-4 trillion AI infrastructure market projection is a useful backdrop: the size of the addressable market is enormous and CoreWeave sits as a pure-play provider that can scale quickly because its product is a differentiated infrastructure layer tuned for GPUs.
Supporting data points
- Q2 sales: $2.6 billion, +112% YoY.
- Adjusted EBITDA doubled YoY to $1.5 billion, suggesting improved operating leverage even while GAAP remains unprofitable (operating loss of $49 million in the quarter).
- Record backlog: $104.2 billion (up 246% YoY), supporting the raised 2026 revenue guidance of $12.4-$13.2 billion.
- Balance sheet and cash flow: free cash flow -$13.65 billion, quarterly capex ~$9.4 billion, interest expense $640 million with expectations of $860-$940 million in Q3, and reported long-term debt around $43.5 billion.
- Valuation metrics: market cap roughly $44.8 billion, enterprise value about $74.6 billion, P/S ~5.9, EV/S ~9.8, P/B ~8.9, EPS negative at -$3.50 and EV/EBITDA ~19.9.
Valuation framing
On the surface, CoreWeave trades at high multiples versus traditional cloud or software businesses: P/S of ~5.9 and EV/S ~9.8. Those figures look stretched relative to slower-growth peers, but CoreWeave's revenue growth trajectory and adjusted EBITDA margin expansion partially justify a premium. Consider that the company is guiding to >$12 billion in revenue for 2026 from a Q2 run-rate that is accelerating, and it converted a record backlog into forward revenue visibility.
That said, the market is right to price in financing and execution risk. Negative free cash flow of roughly -$13.7 billion and quarterly capex of $9.4 billion mean the company remains in a capital-intensive growth phase. The recent ATM and convertible issuance are practical responses to that need, but they dilute equity and increase interest/cash-service obligations. In short: the growth multiple is justified only if CoreWeave converts backlog at acceptable gross margins and reduces the relative drag of capex and interest over the next several quarters.
Catalysts to watch
- Backlog conversion into revenue: sequential bookings-to-revenue conversion in coming quarters. If CoreWeave can show meaningful revenue acceleration and sustained adjusted EBITDA expansion, the stock re-rates.
- Margin improvement: evidence that adjusted EBITDA growth continues and bridges toward GAAP profitability as capex intensity moderates.
- Debt & capital structure moves: successful placement of the $3 billion convertible with manageable dilution terms or refinancing that reduces cash interest burden.
- Product differentiation: traction from multi-rack NVIDIA Vera Rubin NVL72 clusters, cross-region storage acceleration and lower-cost Archive tier helping to defend pricing vs. hyperscalers.
- Strategic partnerships: further validation from ecosystem players (e.g., continued collaboration with NVIDIA or enterprise wins from the Physical AI Field Engineering service).
Trade plan - actionable entry, stop, targets and horizon
Trade stance: long - Core position with strict risk controls.
- Entry price: $80.00 per share. This is a pragmatic entry close to the current price that allows participation while leaving room for intraday volatility.
- Stop-loss: $68.00 per share. A break below $68 signals that the market has re-priced in either heavier dilution or execution failure; cutting at this level preserves capital given the company's capital intensity and 52-week low of $60.55.
- Target price: $120.00 per share. This target assumes continued backlog conversion, margin expansion and stabilization of financing costs, and represents upside from current levels in a scenario where investors re-rate the business on EBITDA growth rather than cash burn fears.
- Horizon: long term (180 trading days). Expect the revenue and margin story to take multiple quarters to play out as backlog converts, new clusters come online, and capital markets digest the recent convertible/ATM raises.
Why 180 trading days? The capex and backlog dynamics mean meaningful improvement in reported operating metrics and cash-flow cadence will take several quarters. Earnings beats and margin progression need time to be digested; 180 trading days gives enough runway for tangible progress while avoiding indefinite exposure to capital markets developments.
Risks (and the counterargument)
CoreWeave's upside is real, but the risk profile is material. Key risks include:
- Financing & dilution risk: The ATM program (up to 35 million shares) and the $3 billion convertible announced on 09/17/2026 increase near-term dilution risk. If equity markets demand higher issuance or convertibles are dilutive on conversion, EPS and equity value could be pressured.
- Interest & cash burn: Interest expense is rising (reported $640 million, expected $860-$940 million in Q3) while free cash flow is deeply negative (-$13.65 billion). Continued high capex could force additional capital raises at unfavorable terms.
- Execution & supply constraints: Converting a large backlog into revenue requires chassis, GPUs and skilled engineering. Supply-chain hiccups or slower rack provisioning could delay revenue recognition and margin expansion.
- Competitive pressure: Larger cloud players and emerging rivals (Microsoft, Nebius Group) can undercut pricing or bundle GPU services with other cloud offerings, pressuring CoreWeave's margin model.
- Macro & AI spending risk: A sudden pullback in enterprise AI spending or a change in GPU pricing dynamics would reduce demand and hurt utilization-driven economics.
Counterargument: It is plausible that demand outpaces CoreWeave's ability to finance capacity, which would keep pricing elevated and margins healthy. If the company successfully converts backlog, improves adjusted EBITDA margins and uses capital markets judiciously to reduce interest burden over the next two quarters, the shares should re-rate materially higher. The balance of evidence today — strong backlog and rising adjusted EBITDA — supports that constructive scenario, but it is not guaranteed.
What would change my mind
I would become more bullish if CoreWeave demonstrates two things in the next two quarters: 1) sustained adjusted EBITDA growth while GAAP losses shrink and free cash flow begins to improve meaningfully; and 2) either a clear pathway to lower net interest (via refinancing) or disciplined capital raising that minimizes equity dilution. Conversely, I would turn bearish if the company issues large incremental equity at weak prices, misses backlog conversion targets, or reports materially higher-than-expected interest and capex that extend the negative free cash flow profile.
Conclusion
CoreWeave sits at an inflection: demand is real and margins are starting to show, but the financing footprint and capex intensity are non-trivial. For investors willing to accept higher volatility, a structured long with an entry near $80, a stop at $68 and a 180-trading-day horizon to allow backlog conversion and margin improvement is a sensible way to capture the upside while protecting capital. Monitor debt servicing costs, capex cadence, and actual backlog-to-revenue conversion closely — those pieces will determine whether CoreWeave earns its premium valuation.
Key trade metrics: Entry $80.00 | Stop $68.00 | Target $120.00 | Horizon: long term (180 trading days) | Risk profile: high